SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2128172

Cover Image

PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2128172

Eubiotics Market Size, Share, Growth, Global Industry Analysis, Regional Insights and Forecast to 2026-2034

PUBLISHED:
PAGES: 200 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4850
Unprintable PDF & Excel (Multi User License)
USD 5850
PDF, Excel & PPT (Enterprise License)
USD 6850

Add to Cart

Growth Factors of eubiotics Market

The global eubiotics market was valued at USD 8.71 billion in 2025 and is projected to grow from USD 9.26 billion in 2026 to USD 16.18 billion by 2034, registering a CAGR of 7.23% during the forecast period. Asia Pacific dominated the market with a 37.08% share in 2025, driven by expanding livestock production, rising feed demand, and increasing adoption of antibiotic-free animal nutrition practices.

Eubiotics are feed additives designed to improve gut microbial balance, nutrient absorption, animal health, and overall production efficiency. These products include probiotics, prebiotics, organic acids, phytogenics, enzymes, and synbiotics. Growing concerns regarding antibiotic resistance and increasing demand for sustainable livestock production are encouraging producers worldwide to adopt eubiotic solutions across poultry, swine, ruminants, and aquaculture sectors.

The market is supported by major animal nutrition companies including DSM-Firmenich, Cargill, Archer Daniels Midland Company, Evonik Industries AG, Novonesis, and Kemin Industries. These companies continue investing in microbial technologies, enzyme engineering, and innovative feed solutions to improve animal performance and reduce dependence on antibiotics.

Market Trends

One of the most significant trends shaping the eubiotics market is the increasing shift toward antibiotic-free livestock production. Governments and regulatory agencies worldwide are restricting antibiotic growth promoters, encouraging farmers to adopt probiotics, phytogenics, organic acids, and synbiotics as natural alternatives.

Another important trend is the development of multifunctional feed additives that combine multiple gut-health benefits in a single formulation. Synbiotics, which combine probiotics and prebiotics, are gaining popularity due to their enhanced effectiveness in improving digestive health and animal productivity.

Market Drivers

Expansion of Global Livestock Production

Growing demand for meat, milk, eggs, and aquaculture products is significantly driving the market. Rising livestock populations require advanced feed solutions that improve feed conversion efficiency, nutrient utilization, and animal health.

Eubiotics help producers achieve higher productivity while maintaining sustainable farming practices. Their ability to improve digestion, immunity, and disease resistance makes them an essential component of modern feed formulations.

Market Restraints

Performance Variability and Regulatory Challenges

The effectiveness of eubiotic products often varies depending on animal species, feed composition, environmental conditions, and farm management practices. This inconsistency can create uncertainty regarding return on investment for livestock producers.

In addition, strict regulatory approval processes require extensive scientific evidence regarding product safety and efficacy, increasing commercialization costs and extending product development timelines.

Market Opportunities

Rapid Growth of Aquaculture Feed Solutions

The expanding aquaculture industry presents a major growth opportunity for eubiotics manufacturers. Fish and shrimp producers increasingly use gut-health additives to improve feed efficiency, disease resistance, survival rates, and production consistency.

As global aquaculture production continues expanding, demand for sustainable feed additives is expected to accelerate significantly throughout the forecast period.

Market Challenges

High Product Development and Validation Requirements

Manufacturers face challenges in developing highly effective formulations that consistently perform across different species and production systems. Extensive research, field trials, and regulatory compliance requirements increase costs and slow market entry for new products.

Segmentation Analysis

By Product Type

The organic acids segment dominated the market in 2025, generating USD 2.42 billion in revenue. Organic acids are widely used to improve feed hygiene, reduce gut pH, and suppress harmful microbial growth.

The synbiotics segment is projected to witness the fastest growth with a CAGR of 8.99%, supported by increasing adoption of combined probiotic and prebiotic solutions.

By Form

The dry segment led the market with a value of USD 7.26 billion in 2025 due to ease of storage, transportation, and incorporation into feed premixes.

The liquid segment is expected to expand at a CAGR of 8.25% through 2034, supported by increasing use in water-based livestock nutrition programs.

By Function

The gut health & nutrition segment accounted for the largest share and reached USD 3.74 billion in 2025. Producers primarily use eubiotics to enhance digestive performance and nutrient absorption.

The immunity segment is expected to register a CAGR of 8.26% during the forecast period.

By Livestock

The poultry segment dominated the market with a value of USD 3.08 billion in 2025, supported by large-scale poultry production and widespread use of feed additives.

The aquaculture segment is projected to grow at the fastest rate, recording a CAGR of 9.03% between 2026 and 2034.

Regional Analysis

Asia Pacific

Asia Pacific emerged as the largest regional market with a value of USD 3.23 billion in 2025 and is forecast to reach USD 6.47 billion by 2034 at a CAGR of 8.13%. China dominated the region with USD 1.33 billion in revenue, while India generated USD 0.45 billion in 2025.

North America

North America was valued at USD 1.84 billion in 2025 and is expected to reach USD 3.27 billion by 2034. The U.S. accounted for approximately USD 1.46 billion of regional revenue due to its large livestock industry and strong focus on antibiotic reduction.

Europe

Europe generated USD 2.17 billion in 2025 and is projected to reach USD 3.70 billion by 2034. Germany contributed USD 0.49 billion, while the U.K. accounted for USD 0.33 billion.

South America and Middle East & Africa

South America reached USD 0.98 billion in 2025 and is expected to attain USD 1.81 billion by 2034. The Middle East & Africa market stood at USD 0.49 billion in 2025 and is forecast to reach USD 0.94 billion by 2034.

Competitive Landscape

Leading companies operating in the global eubiotics market include DSM-Firmenich, Cargill Incorporated, Archer Daniels Midland Company, Evonik Industries AG, Novonesis, Kemin Industries, Alltech Inc., BASF SE, Novus International, and Lallemand Inc.

These companies are focusing on probiotic innovation, enzyme development, microbial technologies, strategic partnerships, and species-specific feed solutions to strengthen their market positions and support sustainable animal nutrition.

Conclusion

The global eubiotics market is witnessing strong growth due to rising demand for antibiotic-free animal nutrition, expanding livestock production, and increasing adoption of functional feed additives. With the market expected to grow from USD 8.71 billion in 2025 to USD 16.18 billion by 2034, opportunities remain substantial across poultry, aquaculture, swine, and ruminant sectors. Continuous innovation in probiotics, synbiotics, enzymes, and microbiome-based nutrition solutions will remain critical in driving future market expansion and improving animal health and production efficiency worldwide.

Segmentation By Product Type

  • Prebiotics
    • Mannan-Oligosaccharides (MOS)
    • Fructo-Oligosaccharides (FOS)
    • Inulin
    • Others
  • Probiotics
    • Lactobacilli
    • Bifidobacterum
    • Streptococcus
    • Others
  • Organic Acids
    • Formic Acid
    • Propionic Acid
    • Butyric Acid
    • Lactic Acid
    • Others
  • Phytogenics
  • Synbiotics
  • Enzymes
  • Others

By Form

  • Dry
  • Liquid

By Function

  • Gut Health & Nutrition
  • Yield & Performance
  • Immunity
  • Others

By Livestock

  • Poultry
  • Swine
  • Ruminants
  • Aquaculture
  • Others

By Region

  • North America (By Product Type, Form, Function, Livestock, and Country)
    • U.S. (By Livestock)
    • Canada (By Livestock)
    • Mexico (By Livestock)
  • Europe (By Product Type, Form, Function, Livestock, and Country)
    • U.K. (By Livestock)
    • Germany (By Livestock)
    • France (By Livestock)
    • Italy (By Livestock)
    • Spain (By Livestock)
    • Rest of Europe (By Livestock)
  • Asia Pacific (By Product Type, Form, Function, Livestock, and Country)
    • China (By Livestock)
    • Japan (By Livestock)
    • India (By Livestock)
    • Australia (By Livestock)
    • Rest of Asia Pacific (By Livestock)
  • South America (By Product Type, Form, Function, Livestock, and Country)
    • Brazil (By Livestock)
    • Argentina (By Livestock)
    • Rest of South America (By Livestock)
  • Middle East & Africa (By Product Type, Form, Function, Livestock, and Country)
    • South Africa (By Livestock)
    • UAE (By Livestock)
    • Rest of the MEA (By Livestock)
Product Code: FBI107717

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Market Overview of Related/Parent Market
  • 4.2. Industry SWOT Analysis
  • 4.3. Recent Industry Developments - Policies, Mergers & Acquisitions, and New Product Launches
  • 4.4. Supply Chain Analysis

5. Global Eubiotics Market Analysis, Insights and Forecast, 2026-2034

  • 5.1. Key Findings / Summary
  • 5.2. Market Size Estimates and Forecast
    • 5.2.1. By Product Type (Value)
      • 5.2.1.1. Prebiotics
        • 5.2.1.1.1. Mannan-Oligosaccharides (MOS)
        • 5.2.1.1.2. Fructo-Oligosaccharides (FOS)
        • 5.2.1.1.3. Inulin
        • 5.2.1.1.4. Others
      • 5.2.1.2. Probiotics
        • 5.2.1.2.1. Lactobacilli
        • 5.2.1.2.2. Bifidobacterum
        • 5.2.1.2.3. Streptococcus
        • 5.2.1.2.4. Others
      • 5.2.1.3. Organic Acids
        • 5.2.1.3.1. Formic Acid
        • 5.2.1.3.2. Propionic Acid
        • 5.2.1.3.3. Butyric Acid
        • 5.2.1.3.4. Lactic Acid
        • 5.2.1.3.5. Others
      • 5.2.1.4. Phytogenics
      • 5.2.1.5. Synbiotics
      • 5.2.1.6. Enzymes
      • 5.2.1.7. Others
    • 5.2.2. By Form (Value)
      • 5.2.2.1. Liquid
      • 5.2.2.2. Dry
    • 5.2.3. By Function (Value)
      • 5.2.3.1. Gut Health & Nutrition
      • 5.2.3.2. Yield & Performance
      • 5.2.3.3. Immunity
      • 5.2.3.4. Others
    • 5.2.4. By Livestock (Value)
      • 5.2.4.1. Poultry
      • 5.2.4.2. Swine
      • 5.2.4.3. Ruminants
      • 5.2.4.4. Aquaculture
      • 5.2.4.5. Others
    • 5.2.5. By Region (Value)
      • 5.2.5.1. North America
      • 5.2.5.2. Europe
      • 5.2.5.3. Asia Pacific
      • 5.2.5.4. South America
      • 5.2.5.5. Middle East and Africa

6. North America Eubiotics Market Analysis, Insights and Forecast, 2026-2034

  • 6.1. Key Findings / Summary
  • 6.2. Market Size Estimates and Forecast
    • 6.2.1. By Product Type (Value)
      • 6.2.1.1. Prebiotics
        • 6.2.1.1.1. Mannan-Oligosaccharides (MOS)
        • 6.2.1.1.2. Fructo-Oligosaccharides (FOS)
        • 6.2.1.1.3. Inulin
        • 6.2.1.1.4. Others
      • 6.2.1.2. Probiotics
        • 6.2.1.2.1. Lactobacilli
        • 6.2.1.2.2. Bifidobacterum
        • 6.2.1.2.3. Streptococcus
        • 6.2.1.2.4. Others
      • 6.2.1.3. Organic Acids
        • 6.2.1.3.1. Formic Acid
        • 6.2.1.3.2. Propionic Acid
        • 6.2.1.3.3. Butyric Acid
        • 6.2.1.3.4. Lactic Acid
        • 6.2.1.3.5. Others
      • 6.2.1.4. Phytogenics
      • 6.2.1.5. Synbiotics
      • 6.2.1.6. Enzymes
      • 6.2.1.7. Others
    • 6.2.2. By Form (Value)
      • 6.2.2.1. Liquid
      • 6.2.2.2. Dry
    • 6.2.3. By Function (Value)
      • 6.2.3.1. Gut Health & Nutrition
      • 6.2.3.2. Yield & Performance
      • 6.2.3.3. Immunity
      • 6.2.3.4. Others
    • 6.2.4. By Livestock (Value)
      • 6.2.4.1. Poultry
      • 6.2.4.2. Swine
      • 6.2.4.3. Ruminants
      • 6.2.4.4. Aquaculture
      • 6.2.4.5. Others
    • 6.2.5. By Country
      • 6.2.5.1. U.S.
        • 6.2.5.1.1. By Livestock
          • 6.2.5.1.1.1. Poultry
          • 6.2.5.1.1.2. Swine
          • 6.2.5.1.1.3. Ruminants
          • 6.2.5.1.1.4. Aquaculture
          • 6.2.5.1.1.5. Others
      • 6.2.5.2. Canada
        • 6.2.5.2.1. By Livestock
          • 6.2.5.2.1.1. Poultry
          • 6.2.5.2.1.2. Swine
          • 6.2.5.2.1.3. Ruminants
          • 6.2.5.2.1.4. Aquaculture
          • 6.2.5.2.1.5. Others
      • 6.2.5.3. Mexico
        • 6.2.5.3.1. By Livestock
          • 6.2.5.3.1.1. Poultry
          • 6.2.5.3.1.2. Swine
          • 6.2.5.3.1.3. Ruminants
          • 6.2.5.3.1.4. Aquaculture
          • 6.2.5.3.1.5. Others

7. Europe Eubiotics Market Analysis, Insights and Forecast, 2026-2034

  • 7.1. Key Findings / Summary
  • 7.2. Market Size Estimates and Forecast
    • 7.2.1. By Product Type (Value)
      • 7.2.1.1. Prebiotics
        • 7.2.1.1.1. Mannan-Oligosaccharides (MOS)
        • 7.2.1.1.2. Fructo-Oligosaccharides (FOS)
        • 7.2.1.1.3. Inulin
        • 7.2.1.1.4. Others
      • 7.2.1.2. Probiotics
        • 7.2.1.2.1. Lactobacilli
        • 7.2.1.2.2. Bifidobacterum
        • 7.2.1.2.3. Streptococcus
        • 7.2.1.2.4. Others
      • 7.2.1.3. Organic Acids
        • 7.2.1.3.1. Formic Acid
        • 7.2.1.3.2. Propionic Acid
        • 7.2.1.3.3. Butyric Acid
        • 7.2.1.3.4. Lactic Acid
        • 7.2.1.3.5. Others
      • 7.2.1.4. Phytogenics
      • 7.2.1.5. Synbiotics
      • 7.2.1.6. Enzymes
      • 7.2.1.7. Others
    • 7.2.2. By Form (Value)
      • 7.2.2.1. Liquid
      • 7.2.2.2. Dry
    • 7.2.3. By Function (Value)
      • 7.2.3.1. Gut Health & Nutrition
      • 7.2.3.2. Yield & Performance
      • 7.2.3.3. Immunity
      • 7.2.3.4. Others
    • 7.2.4. By Livestock (Value)
      • 7.2.4.1. Poultry
      • 7.2.4.2. Swine
      • 7.2.4.3. Ruminants
      • 7.2.4.4. Aquaculture
      • 7.2.4.5. Others
    • 7.2.5. By Country
      • 7.2.5.1. Germany
        • 7.2.5.1.1. By Livestock
          • 7.2.5.1.1.1. Poultry
          • 7.2.5.1.1.2. Swine
          • 7.2.5.1.1.3. Ruminants
          • 7.2.5.1.1.4. Aquaculture
          • 7.2.5.1.1.5. Others
      • 7.2.5.2. U.K.
        • 7.2.5.2.1. By Livestock
          • 7.2.5.2.1.1. Poultry
          • 7.2.5.2.1.2. Swine
          • 7.2.5.2.1.3. Ruminants
          • 7.2.5.2.1.4. Aquaculture
          • 7.2.5.2.1.5. Others
      • 7.2.5.3. France
        • 7.2.5.3.1. By Livestock
          • 7.2.5.3.1.1. Poultry
          • 7.2.5.3.1.2. Swine
          • 7.2.5.3.1.3. Ruminants
          • 7.2.5.3.1.4. Aquaculture
          • 7.2.5.3.1.5. Others
      • 7.2.5.4. Italy
        • 7.2.5.4.1. By Livestock
          • 7.2.5.4.1.1. Poultry
          • 7.2.5.4.1.2. Swine
          • 7.2.5.4.1.3. Ruminants
          • 7.2.5.4.1.4. Aquaculture
          • 7.2.5.4.1.5. Others
      • 7.2.5.5. Spain
        • 7.2.5.5.1. By Livestock
          • 7.2.5.5.1.1. Poultry
          • 7.2.5.5.1.2. Swine
          • 7.2.5.5.1.3. Ruminants
          • 7.2.5.5.1.4. Aquaculture
          • 7.2.5.5.1.5. Others
      • 7.2.5.6. Rest of Europe
        • 7.2.5.6.1. By Livestock
          • 7.2.5.6.1.1. Poultry
          • 7.2.5.6.1.2. Swine
          • 7.2.5.6.1.3. Ruminants
          • 7.2.5.6.1.4. Aquaculture
          • 7.2.5.6.1.5. Others

8. Asia Pacific Eubiotics Market Analysis, Insights and Forecast, 2026-2034

  • 8.1. Key Findings / Summary
  • 8.2. Market Size Estimates and Forecast
    • 8.2.1. By Product Type (Value)
      • 8.2.1.1. Prebiotics
        • 8.2.1.1.1. Mannan-Oligosaccharides (MOS)
        • 8.2.1.1.2. Fructo-Oligosaccharides (FOS)
        • 8.2.1.1.3. Inulin
        • 8.2.1.1.4. Others
      • 8.2.1.2. Probiotics
        • 8.2.1.2.1. Lactobacilli
        • 8.2.1.2.2. Bifidobacterum
        • 8.2.1.2.3. Streptococcus
        • 8.2.1.2.4. Others
      • 8.2.1.3. Organic Acids
        • 8.2.1.3.1. Formic Acid
        • 8.2.1.3.2. Propionic Acid
        • 8.2.1.3.3. Butyric Acid
        • 8.2.1.3.4. Lactic Acid
        • 8.2.1.3.5. Others
      • 8.2.1.4. Phytogenics
      • 8.2.1.5. Synbiotics
      • 8.2.1.6. Enzymes
      • 8.2.1.7. Others
    • 8.2.2. By Form (Value)
      • 8.2.2.1. Liquid
      • 8.2.2.2. Dry
    • 8.2.3. By Function (Value)
      • 8.2.3.1. Gut Health & Nutrition
      • 8.2.3.2. Yield & Performance
      • 8.2.3.3. Immunity
      • 8.2.3.4. Others
    • 8.2.4. By Livestock (Value)
      • 8.2.4.1. Poultry
      • 8.2.4.2. Swine
      • 8.2.4.3. Ruminants
      • 8.2.4.4. Aquaculture
      • 8.2.4.5. Others
    • 8.2.5. By Country
      • 8.2.5.1. China
        • 8.2.5.1.1. By Livestock
          • 8.2.5.1.1.1. Poultry
          • 8.2.5.1.1.2. Swine
          • 8.2.5.1.1.3. Ruminants
          • 8.2.5.1.1.4. Aquaculture
          • 8.2.5.1.1.5. Others
      • 8.2.5.2. India
        • 8.2.5.2.1. By Livestock
          • 8.2.5.2.1.1. Poultry
          • 8.2.5.2.1.2. Swine
          • 8.2.5.2.1.3. Ruminants
          • 8.2.5.2.1.4. Aquaculture
          • 8.2.5.2.1.5. Others
      • 8.2.5.3. Japan
        • 8.2.5.3.1. By Livestock
          • 8.2.5.3.1.1. Poultry
          • 8.2.5.3.1.2. Swine
          • 8.2.5.3.1.3. Ruminants
          • 8.2.5.3.1.4. Aquaculture
          • 8.2.5.3.1.5. Others
      • 8.2.5.4. Australia
        • 8.2.5.4.1. By Livestock
          • 8.2.5.4.1.1. Poultry
          • 8.2.5.4.1.2. Swine
          • 8.2.5.4.1.3. Ruminants
          • 8.2.5.4.1.4. Aquaculture
          • 8.2.5.4.1.5. Others
      • 8.2.5.5. Rest of Asia Pacific
        • 8.2.5.5.1. By Livestock
          • 8.2.5.5.1.1. Poultry
          • 8.2.5.5.1.2. Swine
          • 8.2.5.5.1.3. Ruminants
          • 8.2.5.5.1.4. Aquaculture
          • 8.2.5.5.1.5. Others

9. South America Eubiotics Market Analysis, Insights and Forecast, 2026-2034

  • 9.1. Key Findings / Summary
  • 9.2. Market Size Estimates and Forecast
    • 9.2.1. By Product Type (Value)
      • 9.2.1.1. Prebiotics
        • 9.2.1.1.1. Mannan-Oligosaccharides (MOS)
        • 9.2.1.1.2. Fructo-Oligosaccharides (FOS)
        • 9.2.1.1.3. Inulin
        • 9.2.1.1.4. Others
      • 9.2.1.2. Probiotics
        • 9.2.1.2.1. Lactobacilli
        • 9.2.1.2.2. Bifidobacterum
        • 9.2.1.2.3. Streptococcus
        • 9.2.1.2.4. Others
      • 9.2.1.3. Organic Acids
        • 9.2.1.3.1. Formic Acid
        • 9.2.1.3.2. Propionic Acid
        • 9.2.1.3.3. Butyric Acid
        • 9.2.1.3.4. Lactic Acid
        • 9.2.1.3.5. Others
      • 9.2.1.4. Phytogenics
      • 9.2.1.5. Synbiotics
      • 9.2.1.6. Enzymes
      • 9.2.1.7. Others
    • 9.2.2. By Form (Value)
      • 9.2.2.1. Liquid
      • 9.2.2.2. Dry
    • 9.2.3. By Function (Value)
      • 9.2.3.1. Gut Health & Nutrition
      • 9.2.3.2. Yield & Performance
      • 9.2.3.3. Immunity
      • 9.2.3.4. Others
    • 9.2.4. By Livestock (Value)
      • 9.2.4.1. Poultry
      • 9.2.4.2. Swine
      • 9.2.4.3. Ruminants
      • 9.2.4.4. Aquaculture
      • 9.2.4.5. Others
    • 9.2.5. By Country
      • 9.2.5.1. Argentina
        • 9.2.5.1.1. By Livestock
          • 9.2.5.1.1.1. Poultry
          • 9.2.5.1.1.2. Swine
          • 9.2.5.1.1.3. Ruminants
          • 9.2.5.1.1.4. Aquaculture
          • 9.2.5.1.1.5. Others
      • 9.2.5.2. Brazil
        • 9.2.5.2.1. By Livestock
          • 9.2.5.2.1.1. Poultry
          • 9.2.5.2.1.2. Swine
          • 9.2.5.2.1.3. Ruminants
          • 9.2.5.2.1.4. Aquaculture
          • 9.2.5.2.1.5. Others
      • 9.2.5.3. Rest of South America
        • 9.2.5.3.1. By Livestock
          • 9.2.5.3.1.1. Poultry
          • 9.2.5.3.1.2. Swine
          • 9.2.5.3.1.3. Ruminants
          • 9.2.5.3.1.4. Aquaculture
          • 9.2.5.3.1.5. Others

10. Middle East and Africa Eubiotics Market Analysis, Insights and Forecast, 2026-2034

  • 10.1. Key Findings / Summary
  • 10.2. Market Size Estimates and Forecast
    • 10.2.1. By Product Type (Value)
      • 10.2.1.1. Prebiotics
        • 10.2.1.1.1. Mannan-Oligosaccharides (MOS)
        • 10.2.1.1.2. Fructo-Oligosaccharides (FOS)
        • 10.2.1.1.3. Inulin
        • 10.2.1.1.4. Others
      • 10.2.1.2. Probiotics
        • 10.2.1.2.1. Lactobacilli
        • 10.2.1.2.2. Bifidobacterum
        • 10.2.1.2.3. Streptococcus
        • 10.2.1.2.4. Others
      • 10.2.1.3. Organic Acids
        • 10.2.1.3.1. Formic Acid
        • 10.2.1.3.2. Propionic Acid
        • 10.2.1.3.3. Butyric Acid
        • 10.2.1.3.4. Lactic Acid
        • 10.2.1.3.5. Others
      • 10.2.1.4. Phytogenics
      • 10.2.1.5. Synbiotics
      • 10.2.1.6. Enzymes
      • 10.2.1.7. Others
    • 10.2.2. By Form (Value)
      • 10.2.2.1. Liquid
      • 10.2.2.2. Dry
    • 10.2.3. By Function (Value)
      • 10.2.3.1. Gut Health & Nutrition
      • 10.2.3.2. Yield & Performance
      • 10.2.3.3. Immunity
      • 10.2.3.4. Others
    • 10.2.4. By Livestock (Value)
      • 10.2.4.1. Poultry
      • 10.2.4.2. Swine
      • 10.2.4.3. Ruminants
      • 10.2.4.4. Aquaculture
      • 10.2.4.5. Others
    • 10.2.5. By Country
      • 10.2.5.1. South Africa
        • 10.2.5.1.1. By Livestock
          • 10.2.5.1.1.1. Poultry
          • 10.2.5.1.1.2. Swine
          • 10.2.5.1.1.3. Ruminants
          • 10.2.5.1.1.4. Aquaculture
          • 10.2.5.1.1.5. Others
      • 10.2.5.2. UAE
        • 10.2.5.2.1. By Livestock
          • 10.2.5.2.1.1. Poultry
          • 10.2.5.2.1.2. Swine
          • 10.2.5.2.1.3. Ruminants
          • 10.2.5.2.1.4. Aquaculture
          • 10.2.5.2.1.5. Others
      • 10.2.5.3. Rest of MEA
        • 10.2.5.3.1. By Livestock
          • 10.2.5.3.1.1. Poultry
          • 10.2.5.3.1.2. Swine
          • 10.2.5.3.1.3. Ruminants
          • 10.2.5.3.1.4. Aquaculture
          • 10.2.5.3.1.5. Others

11. Competitive Matrix

  • 11.1. Business Strategies Adopted by Leading Players
  • 11.2. Global Eubiotics Market Ranking Analysis, By Key Manufacturer, 2025

12. Company Profiles

  • 12.1. dsm-firmenich
    • 12.1.1. Overview
    • 12.1.2. Product Description
    • 12.1.3. Financials (Data as available in the public domain and/or on paid databases)
    • 12.1.4. Recent Developments
    • 12.1.5. Similar information has been provided for all the below companies
  • 12.2. Cargill, Incorporated
  • 12.3. Archer Daniels Midland Company
  • 12.4. Evonik Industries AG
  • 12.5. Novonesis
  • 12.6. Kemin Industries
  • 12.7. Alltech Inc.
  • 12.8. BASF SE
  • 12.9. Novus International, Inc.
  • 12.10. Lallemand Inc.

13. Strategic Recommendations

Product Code: FBI107717

List of Tables

  • Table 1: Global Eubiotics Market Revenue (USD Billion), by Region (2021-2034)
  • Table 2: Global Eubiotics Market Revenue (USD Billion), By Product Type (2021-2034)
  • Table 3: Global Eubiotics Market Revenue (USD Billion), By Form (2021-2034)
  • Table 4: Global Eubiotics Market Revenue (USD Billion), By Function (2021-2034)
  • Table 5: Global Eubiotics Market Revenue (USD Billion), by Livestock(2021-2034)
  • Table 6: North America Eubiotics Market Revenue (USD Billion), By Product Type (2021-2034)
  • Table 7: North America Eubiotics Market Revenue (USD Billion), By Form (2021-2034)
  • Table 8: North America Eubiotics Market Revenue (USD Billion), By Function (2021-2034)
  • Table 9: North America Eubiotics Market Revenue (USD Billion), by Livestock(2021-2034)
  • Table 10: North America Eubiotics Market Revenue (USD Billion), by Country (2021-2034)
  • Table 11: U.S. Eubiotics Market Revenue (USD Billion), By Livestock (2021-2034)
  • Table 12: Canada Eubiotics Market Revenue (USD Billion), By Livestock (2021-2034)
  • Table 13: Mexico Eubiotics Market Revenue (USD Billion), By Livestock (2021-2034)
  • Table 14: Europe Eubiotics Market Revenue (USD Billion), By Product Type (2021-2034)
  • Table 15: Europe Eubiotics Market Revenue (USD Billion), By Form (2021-2034)
  • Table 16: Europe Eubiotics Market Revenue (USD Billion), By Function (2021-2034)
  • Table 17: Europe Eubiotics Market Revenue (USD Billion), by Livestock(2021-2034)
  • Table 18: Europe Eubiotics Market Revenue (USD Billion), by Country (2021-2034)
  • Table 19: U.K. Eubiotics Market Revenue (USD Billion), By Livestock (2021-2034)
  • Table 20: Germany Eubiotics Market Revenue (USD Billion), By Livestock (2021-2034)
  • Table 21: Spain Eubiotics Market Revenue (USD Billion), By Livestock (2021-2034)
  • Table 22: Italy Eubiotics Market Revenue (USD Billion), By Livestock (2021-2034)
  • Table 23: France Eubiotics Market Revenue (USD Billion), By Livestock (2021-2034)
  • Table 24: Rest of Europe Eubiotics Market Revenue (USD Billion), By Livestock (2021-2034)
  • Table 25: Asia Pacific Eubiotics Market Revenue (USD Billion), By Product Type (2021-2034)
  • Table 26: Asia Pacific Eubiotics Market Revenue (USD Billion), By Form (2021-2034)
  • Table 27: Asia Pacific Eubiotics Market Revenue (USD Billion), By Function (2021-2034)
  • Table 28: Asia Pacific Eubiotics Market Revenue (USD Billion), by Livestock(2021-2034)
  • Table 29: Asia Pacific Eubiotics Market Revenue (USD Billion), by Country (2021-2034)
  • Table 30: China Eubiotics Market Revenue (USD Billion), By Livestock (2021-2034)
  • Table 31: India Eubiotics Market Revenue (USD Billion), By Livestock (2021-2034)
  • Table 32: Japan Eubiotics Market Revenue (USD Billion), By Livestock (2021-2034)
  • Table 33: Australia Eubiotics Market Revenue (USD Billion), By Livestock (2021-2034)
  • Table 34: Rest of Asia Pacific Eubiotics Market Revenue (USD Billion), By Livestock (2021-2034)
  • Table 35: South America Eubiotics Market Revenue (USD Billion), By Product Type (2021-2034)
  • Table 36: South America Eubiotics Market Revenue (USD Billion), By Form (2021-2034)
  • Table 37: South America Eubiotics Market Revenue (USD Billion), By Function (2021-2034)
  • Table 38: South America Eubiotics Market Revenue (USD Billion), by Livestock(2021-2034)
  • Table 39: South America Eubiotics Market Revenue (USD Billion), by Country (2021-2034)
  • Table 40: Brazil Eubiotics Market Revenue (USD Billion), By Livestock (2021-2034)
  • Table 41: Argentina Eubiotics Market Revenue (USD Billion), By Livestock (2021-2034)
  • Table 42: Rest of South America Eubiotics Market Revenue (USD Billion), By Livestock (2021-2034)
  • Table 43: Middle East & Africa Eubiotics Market Revenue (USD Billion), By Product Type (2021-2034)
  • Table 44: Middle East & Africa Eubiotics Market Revenue (USD Billion), By Form (2021-2034)
  • Table 45: Middle East & Africa Eubiotics Market Revenue (USD Billion), By Function (2021-2034)
  • Table 46: Middle East & Africa Eubiotics Market Revenue (USD Billion), by Livestock(2021-2034)
  • Table 47: Middle East and Africa Eubiotics Market Revenue (USD Billion), by Country (2021-2034)
  • Table 48: South Africa Eubiotics Market Revenue (USD Billion), By Livestock (2021-2034)
  • Table 49: UAE Eubiotics Market Revenue (USD Billion), By Livestock (2021-2034)
  • Table 50: Rest of Middle East and Africa Eubiotics Market Revenue (USD Billion), By Livestock (2021-2034)
  • Table 51: Global Eubiotics Market Ranking Analysis, By Key Manufacturers, 2025

List of Figures

  • Figure 1: Global Eubiotics Market Snapshot (USD Billion), 2025 & 2034
  • Figure 2: Global Eubiotics Market, By Product Type, 2025 and 2034, (USD Billion)
  • Figure 3: Global Eubiotics Market Share (%), By Product Type, 2025
  • Figure 4: Global Eubiotics Market, By Form, 2025 and 2034, (USD Billion)
  • Figure 5: Global Eubiotics Market Share (%), By Form, 2025
  • Figure 6: Global Eubiotics Market, By Function, 2025 and 2034, (USD Billion)
  • Figure 7: Global Eubiotics Market Share (%), By Function, 2025
  • Figure 8: Global Eubiotics Market, By Livestock, 2025 and 2034, (USD Billion)
  • Figure 9: Global Eubiotics Market Share (%), By Livestock, 2025
  • Figure 10: Global Eubiotics Market, By Region, 2025 and 2034, (USD Billion)
  • Figure 11: Global Eubiotics Market Share (%), By Region, 2025
  • Figure 12: North America Eubiotics Market Value (USD Billion), By Product Type, 2025 & 2034
  • Figure 13: North America Eubiotics Market Share (%), By Product Type, 2025
  • Figure 14: North America Eubiotics Market Value (USD Billion), By Form, 2025 & 2034
  • Figure 15: North America Eubiotics Market Share (%), By Form, 2025
  • Figure 16: North America Eubiotics Market, By Function, 2025 and 2034, (USD Billion)
  • Figure 17: North America Eubiotics Market Share (%), By Function, 2025
  • Figure 18: North America Eubiotics Market Value (USD Billion), By Livestock, 2025 & 2034
  • Figure 19: North America Eubiotics Market Share (%), By Livestock, 2025
  • Figure 20: North America Eubiotics Market (USD Billion), by Country, 2025 & 2034
  • Figure 21: North America Eubiotics Market Share (%), by Country, 2025
  • Figure 22: U.S. Eubiotics Market Value (USD Billion), By Livestock, 2025 & 2034
  • Figure 23: U.S. Eubiotics Market Share (%), By Livestock, 2025
  • Figure 24: Canada Eubiotics Market Value (USD Billion), By Livestock, 2025 & 2034
  • Figure 25: Canada Eubiotics Market Share (%), By Livestock, 2025
  • Figure 26: Mexico Eubiotics Market Value (USD Billion), By Livestock, 2025 & 2034
  • Figure 27: Mexico Eubiotics Market Share (%), By Livestock, 2025
  • Figure 28: Europe Eubiotics Market Value (USD Billion), By Product Type, 2025 & 2034
  • Figure 29: Europe Eubiotics Market Share (%), By Product Type, 2025
  • Figure 30: Europe Eubiotics Market Value (USD Billion), By Form, 2025 & 2034
  • Figure 31: Europe Eubiotics Market Share (%), By Form, 2025
  • Figure 32: Europe Eubiotics Market, By Function, 2025 and 2034, (USD Billion)
  • Figure 33: Europe Eubiotics Market Share (%), By Function, 2025
  • Figure 34: Europe Eubiotics Market Value (USD Billion), By Livestock, 2025 & 2034
  • Figure 35: Europe Eubiotics Market Share (%), By Livestock, 2025
  • Figure 36: Europe Eubiotics Market (USD Billion), by Country, 2025 & 2034
  • Figure 37: Europe Eubiotics Market Share (%), by Country, 2025
  • Figure 38: U.K. Eubiotics Market Value (USD Billion), By Livestock, 2025 & 2034
  • Figure 39: U.K. Eubiotics Market Share (%), By Livestock, 2025
  • Figure 40: Germany Eubiotics Market Value (USD Billion), By Livestock, 2025 & 2034
  • Figure 41: Germany Eubiotics Market Share (%), By Livestock, 2025
  • Figure 42: Spain Eubiotics Market Value (USD Billion), By Livestock, 2025 & 2034
  • Figure 43: Spain Eubiotics Market Share (%), By Livestock, 2025
  • Figure 44: Italy Eubiotics Market Value (USD Billion), By Livestock, 2025 & 2034
  • Figure 45: Italy Eubiotics Market Share (%), By Livestock, 2025
  • Figure 46: France Eubiotics Market Value (USD Billion), By Livestock, 2025 & 2034
  • Figure 47: France Eubiotics Market Share (%), By Livestock, 2025
  • Figure 48: Rest of Europe Eubiotics Market Value (USD Billion), By Livestock, 2025 & 2034
  • Figure 49: Rest of Europe Eubiotics Market Share (%), By Livestock, 2025
  • Figure 50: Asia Pacific Eubiotics Market Value (USD Billion), By Product Type, 2025 & 2034
  • Figure 51: Asia Pacific Eubiotics Market Share (%), By Product Type, 2025
  • Figure 52: Asia Pacific Eubiotics Market Value (USD Billion), By Form, 2025 & 2034
  • Figure 53: Asia Pacific Eubiotics Market Share (%), By Form, 2025
  • Figure 54: Asia Pacific Eubiotics Market Value (USD Billion), By Function, 2025 & 2034
  • Figure 55: Asia Pacific Eubiotics Market Share (%), By Function, 2025
  • Figure 56: Asia Pacific Eubiotics Market Value (USD Billion), By Livestock, 2025 & 2034
  • Figure 57: Asia Pacific Eubiotics Market Share (%), By Livestock, 2025
  • Figure 58: Asia Pacific Eubiotics Market (USD Billion), by Country, 2025 & 2034
  • Figure 59: Asia Pacific Eubiotics Market Share (%), by Country, 2025
  • Figure 60: China Eubiotics Market Value (USD Billion), By Livestock, 2025 & 2034
  • Figure 61: China Eubiotics Market Share (%), By Livestock, 2025
  • Figure 62: India Eubiotics Market Value (USD Billion), By Livestock, 2025 & 2034
  • Figure 63: India Eubiotics Market Share (%), By Livestock, 2025
  • Figure 64: Japan Eubiotics Market Value (USD Billion), By Livestock, 2025 & 2034
  • Figure 65: Japan Eubiotics Market Share (%), By Livestock, 2025
  • Figure 66: Australia Eubiotics Market Value (USD Billion), By Livestock, 2025 & 2034
  • Figure 67: Australia Eubiotics Market Share (%), By Livestock, 2025
  • Figure 68: Rest of Asia Pacific Eubiotics Market Value (USD Billion), By Livestock, 2025 & 2034
  • Figure 69: Rest of Asia Pacific Eubiotics Market Share (%), By Livestock, 2025
  • Figure 70: South America Eubiotics Market Value (USD Billion), By Product Type, 2025 & 2034
  • Figure 71: South America Eubiotics Market Share (%), By Product Type, 2025
  • Figure 72: South America Eubiotics Market Value (USD Billion), By Form, 2025 & 2034
  • Figure 73: South America Eubiotics Market Share (%), By Form, 2025
  • Figure 74: South America Eubiotics Market, By Function, 2025 and 2034, (USD Billion)
  • Figure 75: South America Eubiotics Market Share (%), By Function, 2025
  • Figure 76: South America Eubiotics Market Value (USD Billion), By Livestock, 2025 & 2034
  • Figure 77: South America Eubiotics Market Share (%), By Livestock, 2025
  • Figure 78: South America Eubiotics Market (USD Billion), by Country, 2025 & 2034
  • Figure 79: South America Eubiotics Market Share (%), by Country, 2025
  • Figure 80: Brazil Eubiotics Market Value (USD Billion), By Livestock, 2025 & 2034
  • Figure 81: Brazil Eubiotics Market Share (%), By Livestock, 2025
  • Figure 82: Argentina Eubiotics Market Value (USD Billion), By Livestock, 2025 & 2034
  • Figure 83: Argentina Eubiotics Market Share (%), By Livestock, 2025
  • Figure 84: Rest of South America Eubiotics Market Value (USD Billion), By Livestock, 2025 & 2034
  • Figure 85: Rest of South America Eubiotics Market Share (%), By Livestock, 2025
  • Figure 86: Middle East & Africa Eubiotics Market Value (USD Billion), By Product Type, 2025 & 2034
  • Figure 87: Middle East & Africa Eubiotics Market Share (%), By Product Type, 2025
  • Figure 88: Middle East & Africa Eubiotics Market Value (USD Billion), By Form, 2025 & 2034
  • Figure 89: Middle East & Africa Eubiotics Market Share (%), By Form, 2025
  • Figure 90: Middle East & Africa Eubiotics Market, By Function, 2025 and 2034, (USD Billion)
  • Figure 91: Middle East & Africa Eubiotics Market Share (%), By Function, 2025
  • Figure 92: Middle East & Africa Eubiotics Market Value (USD Billion), By Livestock, 2025 & 2034
  • Figure 93: Middle East & Africa Eubiotics Market Share (%), By Livestock, 2025
  • Figure 94: Middle East and Africa Eubiotics Market (USD Billion), by Country, 2025 & 2034
  • Figure 95: Middle East and Africa Eubiotics Market Share (%), by Country, 2025
  • Figure 96: South Africa Eubiotics Market Value (USD Billion), By Livestock, 2025 & 2034
  • Figure 97: South Africa Eubiotics Market Share (%), By Livestock, 2025
  • Figure 98: UAE Eubiotics Market Value (USD Billion), By Livestock, 2025 & 2034
  • Figure 99: UAE Eubiotics Market Share (%), By Livestock, 2025
  • Figure 100: Rest of Middle East and Africa Eubiotics Market Value (USD Billion), By Livestock, 2025 & 2034
  • Figure 101: Rest of Middle East and Africa Eubiotics Market Share (%), By Livestock, 2025
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!